N.-E. Es-Safi et al. / Tetrahedron 62 (2006) 2705–2714
2713
CDCl3) 184.5 (CF3CO), 169.8 (CH3CO), 161.3 (C-7D),
160.8 (C-7A), 158.4 (C-5D), 157.6 (C-5A), 156.7 (C-8aD),
154.3 (C-8aA), 149.5 (C-400E), 149.3 (C-40B), 149.2 (C-30E),
148.8 (C-30B), 132.1 (C-1 E), 131.8 (C-10B), 122.2 (CF3),
121.4 (C-600E), 119.7 (C-600B), 115.1 (C-50E), 114.9 (C-50B),
114.8 (C-2 E), 112.6 (C-2 B), 110.2 (C-4aA), 105.6 (C-8D),
102.7 (C-4aD), 94.3 (C-6A), 93.3 (C-8A), 92.5 (C-6D), 80.5
(C-2C), 76.7 (C-2F), 70.8 (C-3F), 70.2 (C-4C), 66.0 (C-3C),
27.2 (C-4F), 21.1 (CH3CO). ESI-MS m/z: 1437 [MCH]C,
1454 [MCNH4]C, 1459 [MCNa]C.
(eluent, cyclohexane/EtOAc, 80:20) gave 50 mg
(0.05 mmol, 12.5%) of the intermediate compound 16 and
126 mg (0.08 mmol, 40%) of the target product 17, which
1
was obtained as amorphous powder. H NMR (300 MHz,
CDCl3) 7.21 (d, JZ8.1 Hz, 1H, H-50E), 7.06 (d, JZ1.5 Hz,
1H, H-20E), 6.95 (dd, JZ1.5, 8.1 Hz, 1H, H-60E), 6.84 (d,
JZ1.7 Hz, 1H, H-20B), 6.74 (d, JZ8.4 Hz, 1H, H-50B),
6.26 (dd, JZ1.7, 8.4 Hz, 1H, H-60B), 6.19 (s, 1H, H-6A),
6.16 (d, JZ2 Hz, 1H, H-6D), 6.03 (d, JZ2 Hz, 1H, H-8D),
4.95–5.31 (m, 4H, H-2C, H-3C, H-2F, H-3F), 4.87 (d, JZ
3 Hz, 1H, H-4F), 3.4 (q, JZ7 Hz, 2H, CH2CH3), 3.33–3.52
(m, 4H, OCH2CH2O), 2.82 (dd, JZ6.4, 16.2 Hz, 1H,
H-4bC), 2.65 (dd, JZ5.4, 16.2 Hz, 1H, H-4aC), 1.98–2.40
(m, 6H, CH2CH2CH2), 1.1 (t, JZ7 Hz, 3H, CH3CH2). 13C
NMR (125 MHz, CDCl3) 185.6 (COCF3), 171.3 (COO),
170.9 (COO), 160.6 (C-7A), 159.9 (C-7D), 158.1 (C-5A),
157.4 (C-5D), 155.4 (C-8aA), 153.0 (C-8aD), 148.9
(C-30B), 148.5 (3C, C-40B, C-30E, C-40E), 130.1 (C-10B),
129.9 (C-10E), 120.9 (C-60B), 118.8 (C-60E), 117.4 (CF3),
114.4 (2C, C-50B, C-50E), 114.3 (2C, C-20B, C-20E), 103.3
(C-4aA), 101.4 (C-4aD), 94.0 (C-8D), 93.4 (C-6D), 90.5
(C-6A), 78.2 (C-2C), 77.6 (C-2F), 74.5 (C-3C), 72.8 (C-3F),
70.2 (OCH2CH2O), 70.0 (OCH2CH2O), 66.5 (OCH2CH3),
35.1 (2C, CH2CO), 27.1 (C-4), 19.8 (CH2CH2CH2), 13.9
(CH3CH2). ESI-MS m/z: 1581 [MCH]C, 1603 [MCNa]C.
4.2.8. 30,40,5,7-Tetrabenzyloxy-8-trifluoroacetylcatechin-
3-yl glutarate (14). A mixture of 30,40,5,7-tetrabenzyloxy-
8-trifluoroacetylcatechin 6 (400 mg, 0.53 mmol), glutaric
anhydride (183 mg, 1.6 mmol) and 4-(dimethylamino)-
pyridine (5 mg) in pyridine (15 mL) was stirred at 0 8C for
1 h. After stirring for 48 h at room temperature, the reaction
was quenched with water, and extracted with EtOAc. The
combined organic acid phases were washed with brine, and
dried (MgSO4). Filtration, concentration and silica gel
column chromatography (eluent, hexane/EtOAc, 1:1) gave
210 mg (0.24 mmol, 45%) of 14 and 160 mg of 15
1
(0.1 mmol, 19%). H NMR of 14 (300 MHz, CDCl3) 6.99
(d, JZ1.5 Hz, 1H, H-20), 6.901 (d, JZ8.4 Hz, 1H, H-50), 6.84
(dd, JZ1.5, 8.4 Hz, 1H, H-6 ), 6.24 (s, 1H, H-6), 5.3 (m, 1H,
H-3), 4.95 (d, JZ7.8 Hz, 1H, H-2), 2.81 (dd, JZ5.1,
16.0 Hz, 1H, H-4b), 2.72 (dd, JZ5.7, 16.0 Hz, 1H, H-4a),
2.4 (m, 4H, CH2COOR, CH2COOH), 1.7 (m, 2H, CH2-
CH2CH2). 13C NMR (125 MHz, CDCl3) 184.7 (COCF3),
177.5 (COOH), 172.2 (COOR), 159.6 (C-7), 158.0 (C-5),
153.2 (C-8a), 149.2 (C-30), 148.7 (C-40), 130.4 (C-10), 124.3
(C-60), 117.8 (CF3), 116.5 (C-50), 114.4 (C-20), 105.6 (C-8),
102.0 (C-4a), 91.1 (C-6), 78.5 (C-2), 68.4 (C-3), 35.5
(CH2COOH), 33.6 (CH2COOR), 27.9 (C-4), 19.9 (CH2-
CH2COOH). ESI-MS m/z: 861 [MCH]C, 883 [MCNa]C.
4.2.11.
30,40,5,7-Tetrabenzyloxy-8-trifluoroacetyl-
catechin-3-yl-dicyclohexyl-carbodiimidoyl-glutarate
1
(16). H NMR (300 MHz, CDCl3) 7.05 (d, JZ1.5 Hz, 1H,
H-20), 6.95 (d, 0 JZ8.4 Hz, 1H, H-50), 6.78 (dd, JZ1.5,
8.2 Hz, 1H, H-6 ), 6.20 (s, 1H, H-6), 5.1 (d, JZ7.8 Hz, 1H,
H-2), 4.90 (m, 1H, H-3), 2.90 (dd, JZ5.1, 16.0 Hz, 1H, H-
4b), 2.60 (dd, JZ5.7, 16.0 Hz, 1H, H-4a), 2.4 (m, 4H,
CH2CO), 1.6 (m, 2H, CH2CH2CH2), 1.1–2.8 (m, 22H, H
Cyclo). 13C NMR (125 MHz, CDCl3) 184.6 (COCF3), 172.5
(COO), 172.2 (COOC]N), 160.6 (C-7), 158.0 (C-5), 154.1
(C-8a), 153.7 (C]N), 149.2 (C-30), 149.1 (0C-40), 130.6 (C-
10), 120.6 (C-60), 117.4 (CF3), 116.5 (C-5 ), 114.3 (C-20),
105.6 (C-8), 102.0 (C-4a), 91.1 (C-6), 78.4 (C-2), 68.4 (C-
3), 55.7 (CH–N]), 50.0 (CH–NH), 34.1 (CH2–CO), 33.8
(CH2–CO), 33.5 (CH2 Cyclo), 33.5 (CH2 Cyclo), 32.8 (CH2
Cyclo), 32.7 (CH2 Cyclo), 31.1 (CH2 Cyclo), 31.0 (CH2
Cyclo), 27.3 (C-4), 25.6 (CH2 Cyclo), 25.5 (CH2 Cyclo),
24.9 (CH2 Cyclo), 23.2 (CH2 Cyclo), 20.5 (CH2CH2CH2).
ESI-MS m/z: 1067.6 [MCH]C, 1089.6 [MCNa]C.
4.2.9. Di-(5,7,30,40-tetrabenzyloxy-8-trifluoroacetylcate-
chin-3-yl) glutarate (15).0 1H NMR (300 MHz, CDCl3)
7.10 (d, JZ1.5 Hz, 2H, H-2 ), 6.96 (d, JZ8.2 Hz, 2H, H-50),
6.90 (dd, JZ1.5, 8.2 Hz, 2H, H-60), 6.20 (s, 2H, H-6), 5.20
(d, JZ7.8 Hz, 2H, H-2), 4.89 (m, 2H, H-3), 3.02 (dd, JZ
5.1, 15.0 Hz, 2H, H-4b), 2.72 (dd, JZ5.7, 15.0 Hz, 2H,
H-4a), 2.3 (m, 4H, CH2CO), 1.8 (m, 2H, CH2CH2CH2). 13
C
NMR (125 MHz, CDCl3) 185.0 (COCF3), 172.1 (COOR),
160.6 (C-7), 158.0 (C-5), 153.7 (C-8a), 149.2 (C-30), 1480.5
(C-40), 130.2 (C-10), 121.0 (C-60), 117.9 (CF3), 117.5 (C-5 ),
115.1 (C-20), 105.6 (C-8), 102.0 (C4a), 91.1 (C-6),
78.5 (C-2), 68.4 (C-3), 33.5 (CH2CO), 27.5 (C-4),
20.5 (CH2CH2CO). ESI-MS m/z: 1589 [MCH]C, 1611
[MCNa]C.
4.2.12. Octabenzyloxy-3,30-O-glutarylcatechin-(4/6)-8-
trifluoroacetylcatechin (18). To a solution of 17 (100 mg,
0.06 mmol) in CH2Cl2 (20 mL) was added dropwise
TMSOTf (0.11 mL, 0.06 mmol, 0.5 M solution in CH2Cl2)
at 0 8C. After stirring for 5 min, the pale yellow reaction
mixture was quenched with saturated sodium hydrogen
carbonate. The aqueous solution was extracted with CHCl3
and the organic phase was washed with water and brine, and
dried (MgSO4). Filtration, concentration and short silica
gel column chromatography (eluent, cyclohexane/EtOAc,
80:20) afforded 2 mg (0.001 mmol, 2.2%) of 18 as
amorphous powder. 1H NMR (300 MHz, CDCl3) 7.01
(1H, d, J0Z1.5 Hz, 1H, H-20E), 6.90 (1H, dd, JZ1.5, 8.1 Hz,
1H, H-6 E), 6.75 (1H,0 d, JZ1.6 Hz, 1H, H-20B), 6.70 (1H,
d, JZ8.1 Hz, 1H, H-5 E), 6.40 (1H, dd, JZ1.6, 8.3 Hz, 1H,
H-60B), 6.21 (1H, d, JZ8.3 Hz, 1H, H-50B), 6.10 (1H, d,
JZ2.0 Hz, 1H, H-6D), 6.05 (1H, d, JZ2.0 Hz, 1H, H-8D),
4.2.10. 30,40,5,7-Tetrabenzyloxy-4-(2-ethoxyethoxy)-
catechin-3-yl-30,40,5,7-tetrabenzyloxy-8-trifluoroacetyl-
catechin-3-yl glutarate (17). A solution of 30,40,5,7-
tetrabenzyloxy-40-(2-ethoxyethoxy)catechin 8 (150 mg,
0.20 mmol), 30,4 ,5,7-tetrabenzyloxy-8-trifluoroacetylcate-
chin-3-yl glutarate 14 (300 mg, 0.40 mmol), DCC (82.6 mg,
0.40 mmol) and DMAP (10.00 mg) in CH2Cl2 (20 mL) was
stirred at 0 8C for 1 h. After stirring for 12 h at room
temperature, the reaction mixture was quenched with water,
and extracted with CH2Cl2. The combined organic phases
were washed with brine, and dried (MgSO4). Filtration,
concentration and silica gel column chromatography